×
About 1,665 results

ALLMedicine™ Neuromyelitis Optica Spectrum Disorder Center

Research & Reviews  615 results

Localised chiasmal optic neuritis in neuromyelitis optica spectrum disorder.
https://doi.org/10.1136/practneurol-2021-003120
Practical Neurology; Tsunogae M, Yoshimura H et. al.

Oct 23rd, 2021 - Localised chiasmal optic neuritis in neuromyelitis optica spectrum disorder.|2021|Tsunogae M,Yoshimura H,Matsuzaki M,Yokota S,Kawamoto M,|

A preliminary study of association of cigarette smoking with risk of neuromyelitis opti...
https://doi.org/10.1097/MD.0000000000027234
Medicine Yang TT, Yin H et. al.

Oct 20th, 2021 - Various studies have revealed an association between cigarette smoking and increased risk for multiple sclerosis (MS). However, its role in neuromyelitis optica spectrum disorder (NMOSD) remains elusive. Therefore, in the present case-control stud...

Lifestyle Weight Management Program: Interviews and Stakeholder Meetings.
https://clinicaltrials.gov/ct2/show/NCT05070286

Oct 20th, 2021 - RESEARCH QUESTIONS AND AIMS Aim: To co-develop a comprehensive lifestyle weight management program catered specifically for paediatric patients with demyelinating conditions such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorde...

Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis opt...
https://doi.org/10.1016/j.jneuroim.2021.577742
Journal of Neuroimmunology; Nagireddy RBR, Kumar A et. al.

Oct 17th, 2021 - Neuromyelitis Optica spectrum disorders (NMOSD) are autoimmune inflammatory central nervous system diseases. NMOSD patients typically have recurrent attacks of severe optic neuritis or/and myelitis with majority of them having autoantibodies again...

BLK polymorphisms and expression level in neuromyelitis optica spectrum disorder.
https://doi.org/10.1111/cns.13738
CNS Neuroscience & Therapeutics; Yin BW, Li B et. al.

Oct 13th, 2021 - This study aimed to determine the correlation between B-lymphoid tyrosine kinase (BLK) polymorphism, mRNA gene expression of BLK, and NMOSD in a Chinese Han population. B-lymphoid tyrosine kinase gene expressed mainly in B cells plays a key role i...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  5 results

Lifestyle Weight Management Program: Interviews and Stakeholder Meetings.
https://clinicaltrials.gov/ct2/show/NCT05070286

Oct 20th, 2021 - RESEARCH QUESTIONS AND AIMS Aim: To co-develop a comprehensive lifestyle weight management program catered specifically for paediatric patients with demyelinating conditions such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorde...

A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)
https://clinicaltrials.gov/ct2/show/NCT04660539

Aug 18th, 2021 - This multicenter, single-arm, open-label study will evaluate the long-term safety and efficacy of satralizumab in patrticipants with neuromyelitis optica spectrum disorder (NMOSD) who completed open-label extension (OLE) period of studies BN40898 ...

Quantitative T1rho Magnetic Resonance Imaging in Multiple Sclerosis (MS)
https://clinicaltrials.gov/ct2/show/NCT04993196

Aug 6th, 2021 - T1rho imaging is a new MRI technique that has strong potential in neuroimaging. This technique does not require exogenous contrast agents and has high spatial resolution. In this study we aim to characterise the normal appearance of T1rho in the b...

Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein
https://clinicaltrials.gov/ct2/show/NCT03345537

Nov 17th, 2020 - Optic neuritis (ON) have a broad clinical spectrum ranging from a single episode (clinically isolated ON) to demyelinating diseases such as multiple sclerosis (MS), Chronic Relapsing Inflammatory Optic Neuritis (CRION), acute demyelination encepha...

A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
https://clinicaltrials.gov/ct2/show/NCT01892345

Jun 26th, 2019 - The objectives of this time-to-event study were to assess the efficacy and safety of eculizumab as compared with placebo in participants with neuromyelitis optica spectrum disorder (NMOSD) who were anti-aquaporin-4 (AQP4) antibody-positive.

see more →

News  41 results

Common MS Treatment Wears Off More Quickly in Black Patients
https://www.medscape.com/viewarticle/949488

Apr 17th, 2021 - Black patients with multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) may respond differently to common MS treatment compared to their White peers, new research suggests. In a study of almost 200 patients, Black participant...

Newly Approved Drugs Offer New Hope in NMOSD
https://www.medscape.com/viewarticle/947267

Mar 11th, 2021 - While they're extraordinarily expensive, a trio of newly approved medications is providing a variety of effective treatment options for patients with neuromyelitis optica spectrum disorder (NMOSD), a neurologist told colleagues. "Patients have a c...

FDA Approvals, Highlights, and Summaries: Ophthalmology 
https://reference.medscape.com/viewarticle/945191

Feb 24th, 2021 - Enspryng (satralizumab) Satralizumab is indicated for neuromyelitis optica spectrum disorder (NMOSD) in adults who are antiaquaporin-4 (AQP4) antibody positive. It is a humanized monoclonal antibody that targets the interleukin 6 (IL-6) receptor. ...

New Developments, Challenges in Treating NMOSD
https://www.medscape.com/viewarticle/939569

Oct 22nd, 2020 - New developments in treatment of neuromyelitis optica spectrum disorder (NMOSD) have opened up options for disease treatment in pediatric patients, but have led to some uncertainty and confusion as well. At the2020 CNS-ICNA Conjoint Meeting, held ...

New Developments, Challenges in Treating NMOSD
https://www.staging.medscape.com/viewarticle/939569

Oct 22nd, 2020 - New developments in treatment of neuromyelitis optica spectrum disorder (NMOSD) have opened up options for disease treatment in pediatric patients, but have led to some uncertainty and confusion as well. At the2020 CNS-ICNA Conjoint Meeting, held ...

see more →

Patient Education  2 results see all →